Literature DB >> 9222104

Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization.

R Karhu1, M Kähkönen, T Kuukasjärvi, S Pennanen, M Tirkkonen, O Kallioniemi.   

Abstract

With the recent rapid expansion in the use of the comparative genomic hybridization (CGH) technique, increased attention to quality control is essential. In the present study, we show that despite optimization and standardization of metaphase preparation techniques and the commercial availability of metaphase spreads, batch-to-batch variability of the preparations remains a significant problem. To facilitate reliable CGH analysis despite this variability, we have developed a rapid denaturation test to assess the quality of the preparations without hybridization and quantitative image analysis criteria for assuring the day-to-day quality of CGH experiments, including sensitivity, specificity, and dynamic range. Monitoring the dynamic range of the hybridizations was found to be particularly critical for achieving sensitive and reliable CGH results. This reliability can be achieved, for example, by hybridization of a green-labeled normal male DNA against red-labeled female DNA and monitoring of the green:red ratio of the X chromosome in relation to that of the autosomes.

Mesh:

Year:  1997        PMID: 9222104     DOI: 10.1002/(sici)1097-0320(19970701)28:3<198::aid-cyto3>3.0.co;2-a

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

Review 1.  Comparative genomic hybridisation.

Authors:  M M Weiss; M A Hermsen; G A Meijer; N C van Grieken; J P Baak; E J Kuipers; P J van Diest
Journal:  Mol Pathol       Date:  1999-10

2.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.

Authors:  L L Siu; K F Wong; J K Chan; Y L Kwong
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.

Authors:  M M Tanner; R A Karhu; N N Nupponen; A Borg; B Baldetorp; T Pejovic; M Fernö; D Killander; J J Isola
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

4.  Molecular cytogenetic characterization of tenosynovial giant cell tumors.

Authors:  Petter Brandal; Bodil Bjerkehagen; Sverre Heim
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

5.  Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA.

Authors:  S K Lehtinen; N Hance; A El Meziane; M K Juhola; K M Juhola; R Karhu; J N Spelbrink; I J Holt; H T Jacobs
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

6.  Molecular cytogenetic analysis of 11 new breast cancer cell lines.

Authors:  F Forozan; R Veldman; C A Ammerman; N Z Parsa; A Kallioniemi; O P Kallioniemi; S P Ethier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

7.  Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.

Authors:  P M De Angelis; O P Clausen; A Schjølberg; T Stokke
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.